Table 1.
Construct (Amino Acid) | Forward and Reverse Primers (5′–3′) | Positions, bp | Fragment, bp |
---|---|---|---|
hSMVT-GFP | CCGGAATTCATGAGTGTAGGGGTGAGC; | 1-1905 | 1905 |
ACGCGTCGACCAGGGAGGTCTCCTGGAG | |||
hSMVT[1-632]-GFP | CCGGAATTCATGAGTGTAGGGGTGAGC; | 1-1896 | 1896 |
ACGCGTCGACCTCCTGGAGGATGCAGGT | |||
hSMVT[1-624]-GFP | CCGGAATTCATGAGTGTAGGGGTGAGC; | 1-1872 | 1872 |
ACGCGTCGACGCTCCCCTGATAGGCTGTG | |||
hSMVT[1-620]-GFP | CCGGAATTCATGAGTGTAGGGGTGAGC; | 1-1860 | 1860 |
ACGCGTCGACGGCTGCGGCAGCCAGGG | |||
hSMVT[1-616]-GFP | CCGGAATTCATGAGTGTAGGGGTGAGC; | 1-1848 | 1848 |
ACGCGTCGACCGCGGCCATGGCCTCCT | |||
hSMVT[1-612]-GFP | CCGGAATTCATGAGTGTAGGGGTGAGC; | 1-1836 | 1836 |
ACGCGTCGACCTCCTTGTCTCTGCTGTCCC | |||
hSMVT[1-600]-GFP | CCGGAATTCATGAGTGTAGGGGTGAGC; | 1-1800 | 1800 |
ACGCGTCGACCGGCTTCTCAGGAAACAGGC | |||
hSMVT[1-584]-GFP | CCGGAATTCATGAGTGTAGGGGTGAGC; | 1-1752 | 1752 |
ACGCGTCGACCCTGCAGTGGAGCCGCT | |||
hSMVT[1-575]-GFP | CCGGAATTCATGAGTGTAGGGGTGAGC; | 1-1725 | 1725 |
ACGCGTCGACCAACGGAAGGAGGGACA | |||
hSMVT[1-570]-GFP | CCGGAATTCATGAGTGTAGGGGTGAGC; | 1-1710 | 1710 |
ACGCGTCGACCAGGAGCTTTGGCAACACTG | |||
hSMVT[1-567]-GFP | CCGGAATTCATGAGTGTAGGGGTGAGC; | 1-1701 | 1701 |
ACGCGTCGACTGGCAACACTGGGTAAAGG | |||
hSMVT[ΔC]-GFP | CCGGAATTCATGAGTGTAGGGGTGAGC; | 1-1656 | 1656 |
ACGCGTCGACCATTCTCCCAGTGAGTAGACT |
Shown is the combination of primer sequence used to generate full-length and truncated human sodium-dependent multivitamin transporter (hSMVT) constructs by PCR. Restriction sites for EcoRI (underlined) and Sal I (boldface) were added to the hSMVT primers to allow subsequent subcloning into the enhanced green fluorescent protein (GFP-N3) vector. hSMVT[ΔC]-truncation of COOH terminus of hSMVT.